Your browser doesn't support javascript.
loading
A Single Infusion of Zoledronate in Postmenopausal Women Following Denosumab Discontinuation Results in Partial Conservation of Bone Mass Gains.
Everts-Graber, Judith; Reichenbach, Stephan; Ziswiler, Hans Rudolf; Studer, Ueli; Lehmann, Thomas.
Affiliation
  • Everts-Graber J; OsteoRheuma Bern, Bern, Switzerland.
  • Reichenbach S; Department of Rheumatology, Immunology and Allergology, University Hospital, Bern, Switzerland.
  • Ziswiler HR; Institute for Social and Preventive Medicine, Bern, Switzerland.
  • Studer U; OsteoRheuma Bern, Bern, Switzerland.
  • Lehmann T; OsteoRheuma Bern, Bern, Switzerland.
J Bone Miner Res ; 35(7): 1207-1215, 2020 07.
Article in En | MEDLINE | ID: mdl-31991007
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Bone Density Conservation Agents / Zoledronic Acid Type of study: Observational_studies Limits: Female / Humans Language: En Journal: J Bone Miner Res Journal subject: METABOLISMO / ORTOPEDIA Year: 2020 Document type: Article Affiliation country: Switzerland Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Bone Density Conservation Agents / Zoledronic Acid Type of study: Observational_studies Limits: Female / Humans Language: En Journal: J Bone Miner Res Journal subject: METABOLISMO / ORTOPEDIA Year: 2020 Document type: Article Affiliation country: Switzerland Country of publication: United States